Unknown PHASE4 INTERVENTIONAL 2-arm NCT02594423

Strategies for Management of Corneal Neovascularisation

Management of Active and Established Corneal Neovascularisation to Prevent Visual Impairment

Sponsor: University of Nottingham

Interventions Bevacizumab Fine Needle Diathermy

Updated 7 times since 2017 Last updated: Dec 1, 2015 Started: Dec 31, 2015 Primary completion: Aug 31, 2017 Completion: Aug 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02594423, this PHASE4 trial focuses on Corneal Neovascularisation and remains ongoing. Sponsored by University of Nottingham, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Sep 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Sep 2018 [monthly]

Not Yet Recruiting PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Not Yet Recruiting PHASE4

First recorded

Dec 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Nottingham

Data source: University of Nottingham

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.